Management Control in Biomedical Research and Pharmaceutical Innovation PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Management Control in Biomedical Research and Pharmaceutical Innovation PDF full book. Access full book title Management Control in Biomedical Research and Pharmaceutical Innovation by Simon Willem Frederik Omta. Download full books in PDF and EPUB format.
Author: Simon Willem Frederik Omta
Publisher:
ISBN: 9789036704984
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Author: Simon Willem Frederik Omta
Publisher:
ISBN: 9789036704984
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Author: S.W. Omta
Publisher: Springer Science & Business Media
ISBN: 9401101019
Category : Science
Languages : en
Pages : 294
Get Book Here
Book Description
Is talent the only key to scientific success? In fact, the answer is: `No'. Management and organisation do make a real, significant difference between success and failure in science. This book presents a clear survey of the critical success factors in biomedical research laboratories. Based on an international, comparative study of 71 research laboratories in medical faculties, large health research institutes and innovative pharmaceutical companies, ready-to-use guidelines are offered to those who are responsible for the management of research groups. Dr. Omta is biochemist and has played a key role in the development of the EU Biotechnology Network. He has performed the comparative study for this book in the position of Managing Director of the Institute for Research in Extramural Medicine in Amsterdam. The author has recently been appointed as Associate Professor at the Faculty of Management and Organisation at the University of Groningen, the Netherlands. This work is a unique guide for heads, professors, or managers of (biomedical) research laboratories in universities, research institutes and innovative pharmaceutical companies, who are seeking rational tools for increasing the performance and effectiveness of their research groups.
Author: Scott D. Babler
Publisher: John Wiley & Sons
ISBN: 1118058216
Category : Medical
Languages : en
Pages : 283
Get Book Here
Book Description
Pharmaceutical and Biomedical Portfolio Management in a Changing Global Environment explores some of the critical forces at work today in the complex endeavour of pharmaceutical and medical product development. Written by experienced professionals, and including real-world approaches and best practice examples, this new title addresses three key areas – small molecules, large molecules, and medical devices - and provides hard-to-find, consolidated information relevant to and needed by pharmaceutical, biotech, and medical device company managers.
Author: Oliver Gassmann
Publisher: Springer
ISBN: 3319668331
Category : Business & Economics
Languages : en
Pages : 189
Get Book Here
Book Description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Author: Oliver Gassmann
Publisher: Springer Science & Business Media
ISBN: 3540776362
Category : Business & Economics
Languages : en
Pages : 194
Get Book Here
Book Description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Author: Philip A. Rea
Publisher: Cambridge University Press
ISBN: 1107130905
Category : Business & Economics
Languages : en
Pages : 557
Get Book Here
Book Description
Addresses in roughly equal measure the science and management behind several recent marketable biomedical innovations.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309498511
Category : Medical
Languages : en
Pages : 103
Get Book Here
Book Description
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309301718
Category : Medical
Languages : en
Pages : 88
Get Book Here
Book Description
Scientific advances such as the sequencing of the human genome have created great promise for improving human health by providing a greater understanding of disease biology and enabling the development of new drugs, diagnostics, and preventive services. However, the translation of research advances into clinical applications has so far been slower than anticipated. This is due in part to the complexity of the underlying biology as well as the cost and time it takes to develop a product. Pharmaceutical companies are adapting their business models to this new reality for product development by placing increasing emphasis on leveraging alliances, joint development efforts, early-phase research partnerships, and public-private partnerships. These collaborative efforts make it possible to identify new drug targets, enhance the understanding of the underlying basis of disease, discover novel indications for the use of already approved products, and develop biomarkers for disease outcomes or directed drug use. While the potential benefits of collaboration are significant, the fact that the relationships among development partners are often financial means that it is vital to ensure trust by identifying, disclosing, and managing any potential sources of conflict that could create bias in the research being performed together. Conflict of Interest and Medical Innovation is the summary of a workshop convened by the Institute of Medicine Roundtable on Translating Genomic-Based Research for Health in June 2013 to explore the appropriate balance between identifying and managing conflicts of interest and advancing medical innovation. A wide range of stakeholders, including government officials, pharmaceutical company representatives, academic administrators and researchers, health care providers, medical ethicists, patient advocates, and consumers, were invited to present their perspectives and participate in discussions during the workshop. This report focuses on current conflict of interest policies and their effect on medical innovation in an effort to identify best practices and potential solutions for facilitating innovation while still ensuring scientific integrity and public trust.
Author: Dipak Kumar Sarker
Publisher: John Wiley & Sons
ISBN: 0470773049
Category : Science
Languages : en
Pages : 204
Get Book Here
Book Description
Quality Systems and Control for Pharmaceuticals is an accessible overview of the highly-regulated area of pharmaceutical manufacture, the production of biomedical materials, and biomedical devices. Introducing the subject in a clear and logical manner it enables the reader to grasp the key concepts of the multidisciplinary area of control science and specifically quality control using industrial and theoretical models. Taking a multidisciplinary approach to the subject the reader is guided through key topics such as product safety which takes into account aspects of analytical science, statistics, microbiology, biotechnology, engineering, business practice and optimizing models, the law and safeguarding public health, innovation and inventiveness and contemporary best practice. The author has both industry and academic experience and many ‘best practice’ examples are included throughout the text based on his own industry experience and current practicing industrial pharmacists. This is an invaluable reference for all students of pharmacy who may have little or no familiarity with industrial practice and for those studying BSc chemistry, biomedical sciences, process analytical chemistry and MSc in Industrial Practice.
Author: Mile Terziovski
Publisher: Imperial College Press
ISBN: 1860949991
Category : Business & Economics
Languages : en
Pages : 275
Get Book Here
Book Description
Global competition, shorter product lifecycles and increasingly demanding customers are creating significant pressures for the creation of innovative organizations. By examining eight case studies in various industry sectors in Europe, Australia, Japan and Thailand, this book provides a qualitative explanation of the complex relationships between innovation capability, e-commerce, sustainable development and new product development. The book explores how organizations develop innovation capability through the application of e-commerce, sustainable development-orientation, and new product development in order to gain competitive advantage. This knowledge will help managers, academics and policy-makers understand OC what works, and why and how it worksOCO in creating innovation-driven organizations from an international perspective, thereby providing an integrated approach to innovation management. Sample Chapter(s). Chapter 1: Introduction (84 KB). Contents: Development of an Integrated Innovation Capability Model; Strategic Shift from Product Orientation to Innovation Solutions Capability in the German Biotechnology Industry: Sartorius AG; Managing Strategic Change Through Mainstream and Newstream Innovation at Eurocopter, France; Leveraging Innovation Capabilities at Caterpillar Underground Mining (UGM) Pty Ltd; Drivers of Innovation Capability at Sun Microsystems (SMS); Development and Exploitation of Innovation Capability at a Defence Project Engineering Company (DPEC); Drivers of Innovation Capability for Effective Sustainable Development: Best Practice at Vaisala; Developing Innovation Capability Through Intellectual Property Strategy in the Australian Biotechnology Industry: Starpharma; Development of Innovation Capability at Invincible Company in Thailand; Multiple Cross-Case Analysis: Conclusions and Implications. Readership: Managers, academic lecturers, and management researchers; as a supplementary textbook for undergraduates and postgraduates in innovation and technology management."
